The following video is part of our daily MarketFoolery podcast, in which host Chris Hill and analysts Alex Scherer and Jason Moser discuss business and investing news. In this segment, the guys discuss how big pharmaceutical companies are trying to overcome the rise of generic drugs, how intermediary players like CVS and Walgreen are benefiting, and which smaller pharmaceutical companies could be acquisition targets.
Please enable Javascript to view this video.
Merck is one of the companies highlighted in The Motley Fool's report on dividend stocks that are your best bet to beat inflation. It's called "13 High-Yielding Stocks to Buy Today," and you can get access to it right now at no cost. Simply click here -- it's free.
No comments:
Post a Comment